The KEGG analysis indicates that YKD treatment for PCOS may influence several signaling pathways, including the PI3K-Akt signaling pathway, lipid and atherosclerosis signaling pathway, MAPK signaling pathway, and endocrine resistance pathway. Here, AKT1 is linked to polycystic ovary syndrome.